Computer Model

How our livers will store fat?

As part of an effort to understand how an experimental drug for atherosclerosis causes the build-up of fat in the liver, scientists have developed a computer model that can predict how the rate at which liver stores fat in response to various situations.

Computer model developed to predict how \T09\ causes the liver to store fat...
Computer model developed to predict how \'T09\' causes the liver to store fat could be used to predict liver fat storage for other drugs and conditions
Source: Archive

Being able to model liver fat storage gives researchers a way to predict the side effects of drugs and environmental factors at much earlier stages in the research and drug development process, possibly reducing the number of experiments involving animal models. Additionally, this computer simulation helps describe all of the possible ways in which the liver stores fat, including how the liver takes up or creates fats and how it disposes of fat. This knowledge could lay the foundation for future research regarding the liver and its functions.

"Because our computer model can predict how the body responds to a drug over time, it will help to understand and treat diseases in humans and how to develop new drugs with less side effects," said Maaike Oosterveer, Ph.D., a researcher involved in the work from the Department of Pediatrics and Laboratory Medicine at the University Medical Center Groningen in Groningen, Netherlands.

To develop their computer model, Oosterveer and colleagues studied four groups of mice. One group received no treatment at all, while the other three groups were treated with the experimental drug called "T09" for either 1, 7 or 14 days. In each of the four groups, researchers measured several ways in which the liver becomes fatty. These measurements led to the development of the computer model. They then used the model to predict how the ways of fat storage that were not measured in the mice contributed to a fatty liver in the animals receiving the drug, and it provided clues about the how the drug leads to fat storage over time. It predicted that after just one day of drug treatment, more fat is flowing from the bloodstream into the liver. Performing a new experiment in mice confirmed this prediction.

"It's only a matter of time before computers are able to model every system, every disease and every cell in our body," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "This computer model is an important early step toward a future where computers make disease research and drug development much more efficient than it is today."


Details: Brenda S. Hijmans, Christian A. Tiemann, Aldo Grefhorst, Marije Boesjes, Theo H. van Dijk, Uwe J. F. Tietge, Folkert Kuipers, Natal A. W. van Riel, Albert K. Groen, and Maaike H. Oosterveer. A systems biology approach reveals the physiological origin of hepatic steatosis induced by liver X receptor activation. FASEB J. April 2015 29:1153-1164; doi:10.1096/fj.14-254656 ; http://www.fasebj.org/content/29/4/1153.abstract


Source: Federation of American Societies for Experimental Biology

10.04.2015

Read all latest stories

Related articles

Photo

Bioengineering

Producing transplantable livers in the laboratory

Researchers at the Human Genome and Stem Cell Research Center (HUG-CELL), hosted by the University of São Paulo’s Institute of Biosciences (IB-USP) in Brazil, have developed a technique to…

Photo

Regenerative medicine

Lab-grown ‘mini-bile ducts’ to repair human livers

Scientists have used a technique to grow bile duct organoids – often referred to as ‘mini-organs’ – in the lab and shown that these can be used to repair damaged human livers. This is the…

Photo

Microarrays

Taking biomarker research to a new level

Harnessing the potential of digital pathology is taking research into new and more efficient biomarkers to a new level. By combining strategic planning with the latest digital pathology technology,…

Related products

CompuGroup Medical – CGM VT

LIS / Middleware / POCT

CompuGroup Medical – CGM VT

CompuGroup Medical SE
CompuGroup Medical – MOLIS

LIS / Middleware / POCT

CompuGroup Medical – MOLIS

CompuGroup Medical SE
Fujifilm Wako – Autokit Total Ketone Bodies Assay

Clinical Chemistry

Fujifilm Wako – Autokit Total Ketone Bodies Assay

FUJIFILM Wako Chemicals Europe GmbH
Fujifilm Wako – Hyaluronic Acid LT Assay

Clinical Chemistry

Fujifilm Wako – Hyaluronic Acid LT Assay

FUJIFILM Wako Chemicals Europe GmbH
Fujifilm Wako – NEFA-HR(2) Assay

Clinical Chemistry

Fujifilm Wako – NEFA-HR(2) Assay

FUJIFILM Wako Chemicals Europe GmbH
i-Solutions Health – LabCentre

LIS, Middleware, POCT

i-Solutions Health – LabCentre

i-SOLUTIONS Health GmbH
Subscribe to Newsletter